All Disease Treatment & Prevention articles
-
NewsScientists uncover structure of critical component in deadly Nipah virus
Through the structural and functional study of the deadly Nipah virus, a research team has identified a crucial viral component, viral polymerase complex, within its multiplication machinery, with which a part of the enzyme could potentially serve as a therapeutic target.
-
NewsResearch using non-toxic bacteria to fight high-mortality cancers prepares for clinical trials
A promising research study in treating high mortality late-stage cancers with a non-toxic bacterial therapy - BacID - has proven to be safe and more targeted. The newly developed treatment would undergo clinical trials with cancer patients in 2027.
-
NewsEffectiveness and safety of tenofovir amibufenamide in the treatment of chronic hepatitis B: A real-world, multicenter study
A new study aimed to evaluate the real-world effectiveness and safety of tenofovir amibufenamide (TMF) in a cohort of patients with chronic hepatitis B (CHB).
-
NewsAntibiotic treatment for drug-resistant tuberculosis found to be safe and effective in clinical trial
Two clinical trials were conducted to successfully test an oral antibiotic levofloxacin for the preventive treatment of multidrug-resistant tuberculosis (MDR-TB).
-
NewsPromising COVID-19 vaccine development in animal trials
Researchers developed a COVID-19 vaccine that deploys virus-like particles (VLPs) for immunity stimulation in mice.
-
NewsVirus that threatened humanity opens the future
Researchers have developed an innovative therapeutic platform by mimicking the intricate structures of viruses using artificial intelligence.
-
NewsNew guidelines unveil advanced strategies for HIV treatment and prevention
The International Antiviral (formerly AIDS) Society-USA (IAS-USA) has published new international guidelines for the treatment and prevention of HIV, based on significant advances in antiretroviral therapies and new prevention strategies such as pre-exposure prophylaxis.
-
NewsBiomarker test could significantly reduce antibiotic use in sepsis
A major UK patient trial of a new biomarker testing protocol for sepsis, has shown it is possible to safely stop antibiotic treatment earlier than current care.
-
NewsMicrobial load can influence disease associations, new model reveals
Scientists have developed a new machine-learning model to predict microbial load — the density of microbes in our guts — and used it to demonstrate how microbial load plays an important role in disease-microbiome associations.
-
NewsResearch shows new method to safely remove dangerous heart infections without surgery
Doctors used a new catheter-based approach to draw out resistant pockets of infection that settle in the heart, known as right-sided infective endocarditis, without surgery.
-
NewsInnovative bioelectronic device offers new hope in the fight against bacterial infections
Researchers have developed a cutting-edge bioelectronic device that taps into the natural electrical activity of certain bacteria found on our skin, paving the way for a drug-free approach to managing infections.
-
NewsChemists pioneer metallodrug-antibiotic combination strategy to combat superbugs
A combination of different types of antibiotics with bismuth-based drugs, such as Pepto-Bismol, disrupts bacterial iron homeostasis, effectively restoring the bactericidal function of multiple antibiotics.
-
NewsNew bacteria-based therapy shows promise for fighting cancer
Researchers have developed a novel method to enhance the cancer-killing properties of bacteria residing in tumors.
-
News$7 Million grant to tackle lung infections through innovative probiotic treatment
The PROTECT project seeks to combat lung infections by assembling a community of beneficial lung microbes that can outcompete harmful pathogens.
-
NewsLachnospiraceae could be key to successful fecal transplants
Fecal microbiota transplants are a magic bullet for patients with recurring infections from Clostridioides difficile (C. diff), but researchers are only beginning to understand why.
-
NewsResearchers identify antibodies against Klebsiella pneumoniae
Researchers have identified 29 novel antibodies against the bacterium Klebsiella pneumoniae, an important cause of drug-resistant infections.
-
NewsEradivir closes $10.25M Series A funding round for next stage of influenza therapeutic trials
Eradivir, a preclinical biotech company that develops antiviral therapeutics, has completed a $10.25 million Series A funding round which will be used to conduct a Phase 2a challenge study of its EV25 influenza treatment.
-
NewsScientists awarded $90m to prep for future pandemics from understudied viruses
Scientists are laying the groundwork to rapidly respond to potential future pandemics caused by viruses from five understudied families, developing strategies and tools to produce vaccines and antibody-based therapies.
-
NewsWHO data show shock increase in annual cholera deaths
The World Health Organization (WHO) has published global cholera statistics for 2023, showing an increase in cases and deaths.
-
NewsScientists to investigate why men and women are hit by the flu differently
Turns out that there is a biological reason why women and men suffer viral infections like influenza differently – and a team of scientists are extending their research to better understand why and how to design better, possible sex-specific treatments.
